ET-CORMs – Enzyme-triggered CO releasing molecules for therapeutic use
Carbon monoxide (CO), which is endogenously produced mainly in the course of
heme degradation, was recently recognized as a powerful cytoprotective and homeostatic agent. For instance, CO was shown to ameliorate experimental cardiac, lung and vascular injuries and protect against numerous inflammatory states. While the clinical use of CO gas is associated with severe safety problems, a controlled delivery of CO to specific target sites by means of CO-releasing molecules appears to be a most promising solution.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 10
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Detector for continuously monitoring toxic gases
The material could be made as a thin coating to analyze air quality in industrial or home settings over time. Most systems used to detect toxic gases in industrial or…
On the way for an active agent against hepatitis E
In order to infect an organ, viruses need the help of the host cells. “An effective approach is therefore to identify targets in the host that can be manipulated by…
A second chance for new antibiotic agent
Significant attempts 20 years ago… The study focused on the protein peptide deformylase (PDF). Involved in protein maturation processes in cells, PDF is essential for the survival of bacteria. However,…
